Aditya Juloori - Concepedia

Author

Aditya Juloori

University of Chicago ORCID

Also Known As

A Juloori, A. Juloori, ADITYA JULOORI, Aditya Juloori, Henson, Christina, Stephanie Johnson-Obaseki

170

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Chicago Cleveland Clinic The University of Texas MD Anderson Cancer Center Cancer Institute (WIA)Chicago Department of Public Health

About

Aditya Juloori is an author at University of Chicago specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.2K
2	Health Sciences	8	8	352
3	Hepatology	1	1	71
4	Immunology	1	1	12
5	Pathology	1	1	614

Aditya Juloori

Publications

Citations

H-Index

Page 1

	Year	Citations
Non–Small Cell Lung Cancer, Version 4.2024 Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Journal of the National Comprehensive Cancer Network Tumor BiologyActionable Molecular BiomarkersAdvanced Lung DiseaseVersion 4.2024Medicine	2024	614
The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies Joseph M. Kim, Jacob A. Miller, Rupesh Kotecha, Journal of Neuro-Oncology Radiation MedicineRadiation TherapyRadiation NecrosisSurgeryClinical Radiation Oncology	2017	138
A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study Christine M. Bestvina, Kelli B. Pointer, Theodore Karrison, Journal of Thoracic Oncology Adaptive RadiotherapyRadiation MedicineRadiation TherapyMedicineSequential Ipilimumab	2021	122
The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis Rupesh Kotecha, Joseph M. Kim, Jacob A. Miller, Neuro-Oncology	2019	111
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer Stanley I. Gutiontov, William Tyler Turchan, Liam F. Spurr, Scientific Reports	2021	98
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025 A. Dimitrios Colevas, Anthony J. Cmelak, David G. Pfister, Journal of the National Comprehensive Cancer Network	2025	84
A 2D Nanoradiosensitizer Enhances Radiotherapy and Delivers STING Agonists to Potentiate Cancer Immunotherapy Taokun Luo, Geoffrey T. Nash, Xiaomin Jiang, Advanced Materials	2022	71
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma Aditya Juloori, Rohan Katipally, Jeffrey M. Lemons, International Journal of Radiation OncologyBiologyPhysics HepatologyRadiation TherapyMedicineAdvanced/unresectable Hepatocellular CarcinomaRandomized Trial	2022	71
Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy Aditya Juloori, Susan L. Tucker, Ritsuko Komaki, Journal of Thoracic Oncology	2014	69
Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases Shireen Parsai, Jacob A. Miller, Aditya Juloori, Journal of neurosurgery	2019	57

Page 1